IBDEI0BK ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5228,1,4,0)
 ;;=4^T86.10
 ;;^UTILITY(U,$J,358.3,5228,2)
 ;;=^5055708
 ;;^UTILITY(U,$J,358.3,5229,0)
 ;;=T86.11^^27^340^7
 ;;^UTILITY(U,$J,358.3,5229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5229,1,3,0)
 ;;=3^Kidney Transplant Rejection
 ;;^UTILITY(U,$J,358.3,5229,1,4,0)
 ;;=4^T86.11
 ;;^UTILITY(U,$J,358.3,5229,2)
 ;;=^5055709
 ;;^UTILITY(U,$J,358.3,5230,0)
 ;;=T86.12^^27^340^5
 ;;^UTILITY(U,$J,358.3,5230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5230,1,3,0)
 ;;=3^Kidney Transplant Failure
 ;;^UTILITY(U,$J,358.3,5230,1,4,0)
 ;;=4^T86.12
 ;;^UTILITY(U,$J,358.3,5230,2)
 ;;=^5055710
 ;;^UTILITY(U,$J,358.3,5231,0)
 ;;=T86.13^^27^340^6
 ;;^UTILITY(U,$J,358.3,5231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5231,1,3,0)
 ;;=3^Kidney Transplant Infection
 ;;^UTILITY(U,$J,358.3,5231,1,4,0)
 ;;=4^T86.13
 ;;^UTILITY(U,$J,358.3,5231,2)
 ;;=^5055711
 ;;^UTILITY(U,$J,358.3,5232,0)
 ;;=Z94.0^^27^340^8
 ;;^UTILITY(U,$J,358.3,5232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5232,1,3,0)
 ;;=3^Kidney Transplant Status
 ;;^UTILITY(U,$J,358.3,5232,1,4,0)
 ;;=4^Z94.0
 ;;^UTILITY(U,$J,358.3,5232,2)
 ;;=^5063654
 ;;^UTILITY(U,$J,358.3,5233,0)
 ;;=Z48.22^^27^340^1
 ;;^UTILITY(U,$J,358.3,5233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5233,1,3,0)
 ;;=3^Aftercare Following Kidney Transplant
 ;;^UTILITY(U,$J,358.3,5233,1,4,0)
 ;;=4^Z48.22
 ;;^UTILITY(U,$J,358.3,5233,2)
 ;;=^5063039
 ;;^UTILITY(U,$J,358.3,5234,0)
 ;;=Z52.4^^27^340^2
 ;;^UTILITY(U,$J,358.3,5234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5234,1,3,0)
 ;;=3^Kidney Donor
 ;;^UTILITY(U,$J,358.3,5234,1,4,0)
 ;;=4^Z52.4
 ;;^UTILITY(U,$J,358.3,5234,2)
 ;;=^5063082
 ;;^UTILITY(U,$J,358.3,5235,0)
 ;;=D47.Z1^^27^340^9
 ;;^UTILITY(U,$J,358.3,5235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5235,1,3,0)
 ;;=3^Post-Transplant Lymphoproliferative Disorder (PTLD)
 ;;^UTILITY(U,$J,358.3,5235,1,4,0)
 ;;=4^D47.Z1
 ;;^UTILITY(U,$J,358.3,5235,2)
 ;;=^5002261
 ;;^UTILITY(U,$J,358.3,5236,0)
 ;;=T86.10^^27^340^4
 ;;^UTILITY(U,$J,358.3,5236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5236,1,3,0)
 ;;=3^Kidney Transplant Complication,Unspec
 ;;^UTILITY(U,$J,358.3,5236,1,4,0)
 ;;=4^T86.10
 ;;^UTILITY(U,$J,358.3,5236,2)
 ;;=^5055708
 ;;^UTILITY(U,$J,358.3,5237,0)
 ;;=N18.1^^27^341^1
 ;;^UTILITY(U,$J,358.3,5237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5237,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,5237,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,5237,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,5238,0)
 ;;=N18.2^^27^341^2
 ;;^UTILITY(U,$J,358.3,5238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5238,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,5238,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,5238,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,5239,0)
 ;;=N18.3^^27^341^3
 ;;^UTILITY(U,$J,358.3,5239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5239,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,5239,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,5239,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,5240,0)
 ;;=N18.4^^27^341^4
 ;;^UTILITY(U,$J,358.3,5240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5240,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,5240,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,5240,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,5241,0)
 ;;=N18.5^^27^341^5
 ;;^UTILITY(U,$J,358.3,5241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5241,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,5241,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,5241,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,5242,0)
 ;;=N18.9^^27^341^6
